Health Care & Life Sciences » Biotechnology | Amarantus BioScience Holdings Inc.

Amarantus BioScience Holdings Inc.

Amarantus BioScience Holdings Inc.
Stock Exchange Other OTC
EPS
$0.05
Market Cap
$4.68 M
Shares Outstanding
68.27 M
Public Float
60.76 M

Profile

Address
953 Indiana Street
San Francisco California 94104
United States
Employees -
Website http://www.amarantus.com
Updated 07/08/2019
Amarantus BioScience Holdings, Inc. is a biopharmaceutical company, which engages in developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. It focuses on acquiring product and technology rights, raising capital, and performing research and development. The company was founded by Gerald E.

Financials

View All
Created with Highcharts 5.0.14Amarantus BioScience Holdings Inc.Net Income. Fiscal year is January-December. All values USD Thousands.15 13115 13127 27727 27725 21425 21411 58211 5824 4374 43710 38210 38220132014201520162017201805k10k15k20k25k30k

Gerald E. Commissiong
President, Chief Executive Officer & Director
John W. Commissiong
Director & Chief Scientific Officer